Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Current Infectious Disease Reports

Issue 5/2007

Content (13 Articles)

Invited Commentary

The emergence of Chagas disease in the United States and Canada

Louis V. Kirchhoff, Richard D. Pearson

Web alert

Clinical trials report

Jean-Louis Vincent

Sepsis mediators

François Philippart, Jean-Marc Cavaillon

Open Access

Is the septic response good or bad?

Willem Joost Wiersinga, Tom van der Poll

Organ failure in sepsis

Herwig Gerlach, Susanne Toussaint

Long-term outcomes from sepsis

Sachin Yende, Derek C. Angus

Clinical Trials Report

Combating the ascendancy of MRSA: Early efforts in eradication of colonization

Ellie J. C. Goldstein

Community-associated methicillin-resistant Staphylococcus aureus: Incidence, clinical presentation, and treatment decisions

Fredrick M. Abrahamian, Eric W. Snyder

Treatment of community-associated methicillin-resistant Staphylococcus aureus

Kyle J. Popovich, Bala Hota, Robert A. Weinstein

New drugs to treat skin and soft tissue infections

Gary E. Stein

Severe skin and soft tissue infections and associated critical illness

Donald C. Vinh, John M. Embil

Treatment of pediatric HIV infection

Elisa Antonielli d’Oulx, Elena Chiappini, Maurizio de Martino, Pier-Angelo Tovo

Jul 07
Issue: 4/2007
Nov 07
Issue: 6/2007

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits